Navidea Biopharmaceuticals
19 clinical trials · Sponsor
◉ Watch Navidea Biopharmaceuticals
| Record | Firm | Date |
|---|---|---|
| Tc 99m Tilmanocept Imaging for Early Prediction of Anti-TNFα Therapy Response in Moderate to Severe Active RA (NCT05246280) | Navidea Biopharmaceuticals | 2022-03-02 |
| Development of a Normative Database for Rheumatoid Arthritis (RA) Imaging With Tc99m Tilmanocept (NCT04947137) | Navidea Biopharmaceuticals | 2021-05-27 |
| Evaluation of the Precision and Sensitivity of Tilmanocept Uptake Value (TUV) on Tc 99m Tilmanocept Planar Imaging (NCT03938636) | Navidea Biopharmaceuticals | 2019-04-08 |
| Safety Evaluation of IV Tc 99m Tilmanocept and Comparison of Imaging With Sulfur Colloid in Subjects With and Without NASH (NCT03332940) | Navidea Biopharmaceuticals | 2017-12-06 |
| An Evaluation of Tc 99m Tilmanocept by Intravenous (IV) and Subcutaneous (SC) Injection in Kaposi Sarcoma (KS) (NCT03157167) | Navidea Biopharmaceuticals | 2017-12-01 |
Track Navidea Biopharmaceuticals automatically
Every clearance here is in the API, with alerts when new ones post.